SATURDAY May 31, 2014, 2014 — A new oral drug called lenvatinib looks promising as a treatment for a type of thyroid cancer that resists standard radiation, according to a later-stage clinical trial. “We are confident that, based on our findings, lenvatinib will eventually become a…
Source:New Drug Shows Promise for Resistant Thyroid Cancer
Saturday, May 31, 2014
New Drug Shows Promise for Resistant Thyroid Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment